1. Elhai M et al. Ann Rheum Dis 2017;76:1897–905.
2. Hoffmann-Vold AM et al. Am J Respir Crit Care Med 2019;200:1258–66.
3. Volkmann ER et al. Ann Rheum Dis 2019;78:122–30.
4. Distler O et al. N Engl J Med 2019;380:2518–28.

The SENSCIS trial was funded by Boehringer Ingelheim. Editorial and formatting assistance, supported financially by Boehringer Ingelheim, was provided by Julie Fleming and Wendy Morris of FleishmanHillard Fishburn, London, UK during preparation of this poster. The authors were fully responsible for all content and editorial decisions, were involved at all stages of poster development and have approved the final version. Boehringer Ingelheim was given the opportunity to review the poster for medical and scientific accuracy as well as intellectual property considerations. The authors received no direct compensation related to the development of this poster. Toby M Maher reports grants and personal fees from GlaxoSmithKline and UCB; and personal fees from Apellis, Bayer, Biogen Idec, Blade, Boehringer Ingelheim, Bristol-Myers Squibb, Galapagos, Galecto, Indalo, Novartis, Respivent, Roche, and Trevi. Shervin Assassi reports grants, personal fees and other remuneration from Boehringer Ingelheim; grants from Bayer, Biogen Idec, and Momenta; and personal fees from Medscape, Integrity Continuing Education, and Corbus.